Research Directory

Value-based drug pricing coming soon in UK

Read more

Diabetes reimbursement at risk in Germany

Read more

2012 was the year of the antibody developer

Read more

Adaptive licensing: A new approach for drug approvals

Read more

EU Transparency Directive: changes afoot on pricing and reimbursement

Read more

Encode project produces many findings

Read more

German drug policy puts pressure on prices in Europe

Read more

Advances in DNA sequencing drive medical discovery

Read more

Avastin vs Lucentis: the drug reimbursement dilemma of the century

Read more

What lies ahead for AstraZeneca

Read more